Viking Therapeutics, Inc. (VKTX)
31.03
-0.07
(-0.23%)
USD |
NASDAQ |
Feb 20, 16:00
31.01
-0.02
(-0.06%)
Pre-Market: 20:00
Viking Therapeutics SG&A Expense (Quarterly) : 11.28M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.132B |
| Pfizer Inc. | 4.162B |
| Amgen, Inc. | 1.952B |
| Hims & Hers Health, Inc. | 312.83M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |